Yahoo Web Search

    • 4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq

      Morningstar· 1 hour ago

      ...the microbiome, today announces that on June 27, 2022, it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that in accordance with Listing Rules 5101, 5110(b), and IM-5101-1, Nasdaq filed with the Securities and Exchange Commission, which will remove 4D pharma’s...